Prioritize indications based on payer value
Evolve your market access strategy according to internal and external trends, challenges, and opportunities
Develop innovative agreements
Maximize your asset’s value throughout the lifecycle
Our proprietary custom value assessment framework, based on Multiple-Criteria Decision Analysis (MCDA) techniques, is used to map and compare key value drivers across products and indications.
Our Payer and KOL council network of more than 100 international experts, offers a rich source of expert value feedback.
Our unrivalled global database of early and alternative access pathways.